Robert G. Koblin
Corporate Officer/Principal at Robertson Diagnostic Center
Profile
Robert G.
Koblin has been a Director of Signalife, Inc. since July 11, 2008.
He has been Staff Physician and Instructor at the Cedars-Sinai Medical Center in Los Angeles since 1966, Managing Director of the Robertson Diagnostic Center in Beverly Hills, California since April 2002 and an Assistant Clinical Professor of Medicine at the University of California in Los Angeles since 1982.
Dr. Koblin has more than 30 years of medical experience.
Previously, he was a Director of Signalife from February 2003 to March 2005.
Dr. Koblin received an undergraduate degree from New York University and a Medical degree from Stanford University.
Robert G. Koblin active positions
| Companies | Position | Start |
|---|---|---|
| Robertson Diagnostic Center | Corporate Officer/Principal | 2002-03-31 |
| University of California, Los Angeles | Corporate Officer/Principal | 1981-12-31 |
Former positions of Robert G. Koblin
| Companies | Position | End |
|---|---|---|
Signalife, Inc.
 Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Director/Board Member | 2009-06-09 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Director/Board Member | 2005-02-28 |
Training of Robert G. Koblin
| Stanford University | Doctorate Degree |
| New York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Health Technology |
| Robertson Diagnostic Center |
- Stock Market
- Insiders
- Robert G. Koblin